Position

• Professor, University of New Mexico School of Medicine, Albuquerque, NM
• Chair, Mood Disorders Work Group, University of New Mexico School of Medicine, Albuquerque, NM

Board Certifications

• Psychiatry, American Board of Psychiatry and Neurology

Education

• MD, Yale University School of Medicine, New Haven, CT
• Fellowship, National Institute of Mental Health Clinical Center, Bethesda, MD

Dr. Fawcett is a distinguished researcher in the fields of suicide prevention and treatment of affective disorders. He served as the Stanley Harris, Sr. Chairman of the Department of Psychiatry at Rush Medical College in Chicago for thirty years. Dr. Fawcett has also been awarded the Dr. Jan Fawcett Humanitarian Award by the Depression and Bipolar Support Alliance and lifetime research awards by the American Association of Suicidology and the American Foundation for Suicide Prevention.

Dr. Fawcett is a co-author of the APA Practice Guidelines on the assessment and management of suicidal patients and is the chairperson of the DSM-V Mood Disorders Work Group through 2012. In addition to teaching and research duties, Dr. Fawcett has always maintained an active clinical practice focusing on patients with treatment resistant major affective disorders.

Position

• Professor Emeritus of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA
• Chief of the Schizophrenia Clinic, Stanford University School of Medicine, Stanford, CA
• Senior Science Advisor to the Director of the National Institute of Health (NIMH)

Board Certifications

• Psychiatry, American Board of Psychiatry and Neurology

Education

• MD, New York Medical College, Valhalla, NY
• Residency, Mount Zion Medical Center, San Francisco, CA
• Residency, Hillside Hospital, Glen Oaks, NY
• Internship, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA

Dr. Glick has an extensive background in research, education and academic medicine. He has been a professor at three prestigious medical schools (University of California, San Francisco, Cornell and Stanford) as well as the founder and long-time board member of American Society of Clinical Psychopharmacology (ASCP). He is internationally recognized for his broad expertise in education, research and clinical care and as an ardent advocate for consumer organizations. In 2008 he received the American College of Psychiatry’s highest award – The Distinguished Service in Psychiatry Award as well as the Association of Academic Psychiatry’s Distinguished Life Fellowship status. In 2010, he received one of the National Alliance on Mental Illness (NAMI) exemplary Psychiatrist Awards.

Position

• Adjunct Assistant Professor of Psychiatry, University of Illinois, Chicago, IL
• Executive Director, American Physician Institute for Advanced Professional Studies, Oak Brook, IL

Board Certifications

• Psychiatry, American Board of Psychiatry and Neurology

Education

• MD, University of Illinois Abraham Lincoln School of Medicine, Chicago, IL
• Residency, Dept. of Psychiatry, University of Illinois Medical Center and Clinics at Chicago, Chicago, IL
• Fellowship, Senior Staff Fellow at the National Institute on Aging, National Institutes of Health, Bethesda, MA

Dr. Krasuski spent three years as a Senior Staff Fellow at the National Institute on Aging, NIH, where he did research in the neuroimaging of dementing disorders. Currently, he spends most of his time lecturing to thousands of physicians yearly on psychiatric topics. He is known for his ability to clearly explain complex and little understood topics.

Position

• Associate Clinical Professor of Psychiatry, University of California, San Diego, CA
• Staff Psychiatrist, VA San Diego Healthcare System, San Diego, CA
• Attending Psychiatrist, UCSD Medical Center, San Diego, CA

Board Certifications

• Psychiatry, American Board of Psychiatry and Neurology

Education

• MD, Harvard Medical School, Boston, MA
• Fellowships in Clinical Psychopharmacology Research & Consultation/Liaison Psychiatry, Los Angeles County-USC Medical Center, Los Angeles, CA
• Residency, Los Angeles County-USC Medical Center, Los Angeles, CA

In addition to an active clinical practice, Dr. Meyer has published numerous articles and chapters on various aspects of antipsychotic psychopharmacology, the pharmacokinetics of atypical antipsychotics, metabolic effects of atypical antipsychotics, and health outcomes in patients with schizophrenia. Dr. Meyer’s current research focus is the metabolic syndrome in patients with schizophrenia and he is also the recipient of a 5 year, (NIMH)-funded Career Development Award in this area. Dr. Meyer is a nationally-renowned speaker on the subject of side effects and metabolic issues surrounding antipsychotic therapy and is chief editor of a recent book on the topic of medical illness and schizophrenia.

Position

• Leonard M. Miller Professor and Chairman, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL
• Interim Director, Center on Aging, University of Miami Miller School of Medicine, Miami, FL

Board Certifications

• Psychiatry and Geriatric Psychiatry, American Board of Psychiatry and Neurology

Education

• PhD, University of North Carolina, Chapel Hill, NC
• MD, University of North Carolina, Chapel Hill, NC
• Residency in Psychiatry, North Carolina Memorial Hospital, University of North Carolina, Chapel Hill, NC
• Residency in Psychiatry, Duke University Medical Center, Durham, NC

Dr. Nemeroff is a leading expert in the field of psychiatry. Over the last 30 years, Dr. Nemeroff has participated in more than 800 invited lectures on topics such as the neurobiology of depression and anxiety, psychopharmacology, and the neurobiology of child abuse.

Dr. Nemeroff, a distinguished fellow of the American Psychiatric Association, is actively involved with numerous associations. He is a past president of the American College of Neuropsychopharmacology and the American College of Psychiatrists. Dr. Nemeroff serves on the Board of Directors for the American Foundation for Suicide Prevention and the National Foundation for Mental Health. He is also on the Scientific Council of the National Alliance for Research on Schizophrenia and Depression (NARSAD) and the National Alliance for the Mentally Ill (NAMI).

Dr. Nemeroff has published hundreds of scholarly journal articles and more than 20 books, such as Principles of Psychopharmacology for Mental Health Professionals and four editions of Textbook of Psychopharmacology. He is on the editorial board of several peer-reviewed publications such as Directions in Psychopharmacology, Depression and Anxiety, and Journal of Neuropsychiatry and Clinical Neurosciences

Position

• Professor, Case Western Reserve University School of Medicine, Cleveland, OH
• Adjunct Professor, Case Western Reserve University School of Law, Cleveland, OH
• Director, Division of Forensic Psychiatry, Case Western Reserve University, Cleveland, OH

Board Certifications

• Psychiatry, Forensic Psychiatry, American Board of Psychiatry and Neurology

Education

• MD, Case Western Reserve University, Cleveland, OH
• Fellowship, William Beaumont Hospital, El Paso, TX
• Residency, University Hospitals of Cleveland, Cleveland, OH

Dr. Phillip J. Resnick is a leading international authority on forensic psychiatry, specializing in the clinical prediction of the risk of violence and the assessment of malingering and deception. He has consulted on and / or provided expert testimony as a witness on a number of well-known criminal cases including those of Jeffrey Dahmer, Timothy McVeigh, Susan Smith, Andrea Yates and the Unabomber. Dr. Resnick is also a past president of the American Academy of Psychiatry and the Law. He has written extensively on forensic topics and is widely considered to be one of the most outstanding speakers in the field of forensic psychiatry today.